Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2011 Dec;20(122):215-7.
doi: 10.1183/09059180.00007311.

A decade of achievement in pulmonary hypertension

M Humbert, G Simonneau, L J Rubin
Editorial

A decade of achievement in pulmonary hypertension

M Humbert et al. Eur Respir Rev. 2011 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Statement of Interest

M. Humbert has relationships with drug companies including Actelion, AstraZeneca, Bayer-Schering, Chiesi, GSK, Lilly, MSD, Novartis, Nycomed, Pfizer and United Therapeutics. In addition to being an investigator in trials involving these companies, relationships include consultancy service and membership of scientific advisory boards. G. Simonneau has relationships with drug companies including Actelion, Bayer-Schering, GSK, Lilly, Novartis, Pfizer and United Therapeutics. In addition to being an investigator in trials involving these companies, relationships include consultancy service and membership of scientific advisory boards. L. J. Rubin has acted on a scientific advisory committee for United Therapeutics and has acted as a consultant for NHLBI, Actelion, Pfizer, United Therapecthics, LungRx, Gilead, Aires Pharmaceuticals, GSK, Bayer, GeNO and Cytokinetics. He holds shares for United Therapeutics.

References

    1. Aronson JK. Rare diseases and orphan drugs. Br J Clin Pharmacol 2006; 61: 243–245. - PMC - PubMed
    1. Jardim C, Hoette S, Souza R. Contemporary issues in pulmonary hypertension. Eur Respir Rev 2010; 19: 266–271. - PMC - PubMed
    1. Hatano S, Strasser T. Primary Pulmonary Hypertension. Geneva, World Health Organization, 1975.
    1. Simonneau G, Galiè N, Rubin LJ, et al. . Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43: Suppl. 12, 5S–12S. - PubMed
    1. Simonneau G, Robbins IM, Beghetti M, et al. . Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54: Suppl. 1, S43–S54. - PubMed

Publication types

Substances